Life Science Topics - Pharmaceutical Companies

In-House Costs for Existing Systems For an existing in-house system, calculate the total cost of ownership for: Researching current regulations and making system updates Pulling transaction data from multiple sources Preparing transaction data for import into the reporting system Validating HCP information Remediating conflicting data from multiple data sources Generating reports to meet complex federal, [...]

On April 7th, MediSpend hosted the webinar What Does the CCPA Mean for Life Sciences Companies, where we provided an overview of the California Consumer Privacy Act (CCPA) requirements based on the most recent guidance. We also discussed many of the complicated intricacies of establishing CCPA controls impacting life science organizations today. Some of the [...]

You know you need to modernize and improve your transparency reporting program. But how? In a recent assessment of aggregate-spend tracking and transparency reporting technologies in the life sciences industry, Gartner shared, “We do not recommend building an internal solution.” Instead, they suggest partnering with solution providers who have purpose-built and mature technology supported by [...]

Are you a small pharmaceutical or medical device company with limited resources worried about implementing a software solution like MediSpend? Are you a larger organization concerned with already overbooked IT resources or a global organization worried about meeting different business requirements from compliance stakeholders around the globe? No worries! MediSpend has a team of seasoned [...]

If you have not considered an integrated HCP engagement and transparency reporting solution, you should. Here’s why: Hand in hand with developing new treatments and cures, life sciences companies play an important role in educating healthcare practitioners (HCPs) and patients about those drugs and devices. Partnerships between HCPs and healthcare organizations (HCOs) are critical and [...]

On March 11, days before most U.S. businesses across the country had to close their doors to fight the spread of COVID-19, the California Attorney General (AG) provided notice of a second set of modifications to the proposed California Consumer Privacy Act (CCPA) regulations. The period window for submitting comments was between March 11, 2020 [...]

Transparency reporting requirements for life sciences companies are increasing all over the world. The United States was the first country to enact comprehensive transparency reporting requirements for life sciences companies as part of the Patient Protection and Affordability Care Act in 2010. Known as Open Payments, the law requires annual reporting by applicable manufacturers to [...]

An effective technology solution should follow the seven steps outlined below to ensure a systematic methodology is in place to apply controls throughout the healthcare professional (HCP) engagement process in order to reduce the risk of improper payments. Needs Assessment and/or Event Justification: A needs assessment process documents a defined, legitimate business, medical or scientific [...]

For years, industry payments to physicians have been scrutinized by enforcement agencies, politicians and watchdog groups. In fact, the government has been playing an active role in monitoring these transfers of values for years through an increasing number of physician payment reporting laws that started with the state of Minnesota in 1993. Shortly thereafter, California, [...]

On November 15, 2019, the Centers for Medicare & Medicaid Services (CMS) published the final 2020 Physician Fee Schedule which, along with the October 2018 passing of Section 6111 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act), introduces several changes to the Open Payments Program.[1] [...]